Log in or Sign up for Free to view tailored content for your specialty!
Sarcoma News
CAR T-cell therapy shows vaccine effect in child with advanced sarcoma
The prognosis typically is poor for patients with metastatic rhabdomyosarcoma.
NCI scientist receives Samuel D. Gross Prize for surgical research
Renowned cancer researcher Steven A. Rosenberg, MD, PhD, has been awarded the 2020 Samuel D. Gross Prize for surgical research.
Log in or Sign up for Free to view tailored content for your specialty!
Cleveland Clinic appoints department chair
Jae Jung, PhD, has been appointed chair of Cleveland Clinic Lerner Research Institute’s department of cancer biology.
Black children less likely to receive proton therapy than white children
Black children with solid cancers appeared less likely to receive proton radiotherapy than their white counterparts, according to an analysis of Children’s Oncology Group trial data published in a research letter in JAMA Oncology.
Tumor rupture linked to worse outcomes among patients with GIST
Tumor rupture appeared associated with shorter OS among patients treated with or without imatinib after surgery for gastrointestinal stromal tumors, or GIST, according to results of a post-hoc observational study published in JAMA Surgery.
Germline mutations common among young adults with early-onset cancers
Young adults with early-onset cancers appeared at increased risk for harboring specific germline mutations, according to study results presented at the American Association for Cancer Research Virtual Annual Meeting II.
Longer-term imatinib treatment extends OS among patients with GIST
An extended course of imatinib increased OS among patients with gastrointestinal stromal tumors, or GIST, according to long-term study results presented during the ASCO20 Virtual Scientific Program.
First-line doxorubicin plus trabectedin effective, safe for metastatic leiomyosarcoma
Doxorubicin in combination with trabectedin appeared to be an effective and safe first-line therapy for metastatic leiomyosarcoma, according to results of the phase 2 LMS-02 study presented during the ASCO20 Virtual Scientific Program.
FDA approves Pomalyst as first new Kaposi sarcoma treatment in 20 years
The FDA granted accelerated approval to pomalidomide for treatment of two forms of Kaposi sarcoma.
ASCO awards recognize outstanding contributions to cancer care
ASCO announced the recipients of several awards intended to honor researchers and other leaders in oncology who strive to transform cancer care.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read